science top stories popular news  

Daily non-political popular news in brief.

ACPM concludes insufficient evidence to recommend routine prostate cancer screening

01-28-2008 · EurekAlert!

The American College of Preventive Medicine has found there is insufficient evidence to recommend for or against routine population prostate screening with digital rectal examination or measurement of the serum tumor marker, prostatespecific antigen. ACPM advises that clinicians caring for men, especially African-American men and those with a family history, should provide information about the potential benefits and harms of screening and limits of current evidence to allow for them to make an informed decision about screening.

Read more »

Keywords: acpm, concludes, insufficient, evidence, recommend, routine, prostate, cancer, screening, conclude

« Previous | Next »

Similar news on "ACPM concludes insufficient evidence to recommend routine prostate cancer screening":

  1. Simple interventions may increase prostate cancer screening
    07-10-2007 · EurekAlert!
    Prostate cancer is the most common cancer in American men (estimated incidence of 234,460 cases, 27,360 deaths in 2006). Screening remains controversial due to insufficient evidence to recommend for or against screening. Strategies for encouraging discussion of prostate cancer in high-risk populations have not been tested. In a study in the American Journal of Preventive Medicine, August researchers examined the effects of two low-literacy interventions on discussions about, and screening tests for, prostate cancer.
    Similar news · Read more »
  2. Elderly, ill men get unneeded prostate cancer screenings
    11-14-2006 · EurekAlert!
    A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age.
    Similar news · Read more »
  3. Should the UK lower the age for prostate cancer detection?
    11-16-2007 · EurekAlert!
    Prostate cancer screening occurs in many countries ahead of evidence from ongoing trials. In many countries, early detection (including the UK, when practised), and opportunistic screening commences at 50 years, but a lower age limit has recently been adopted in the USA based on two studies that found elevated prostate specific antigen levels in men in their 40s was associated with subsequent prostate cancer.
    Similar news · Read more »
  4. Reactions to 'false-positive' prostate cancer screenings assessed
    03-02-2007 · EurekAlert!
    Men who get a "false-positive" prostate cancer result -- an abnormal screening test followed by a biopsy indicating no evidence of cancer -- appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with normal screening results.
    Similar news · Read more »
  5. New research supports early testing for prostate cancer
    05-20-2007 · EurekAlert!
    Research presented today during the 102nd Annual Scientific Meeting of the American Urological Association in Anaheim, Calif., provided further evidence supporting regular prostate-cancer screening and offered new insights into disease progression and the hormonal treatment of recurrent disease. A special session for media highlighting this research was held on May 20 at 9:00 a.m. PDT and was moderated by AUA spokesman Christopher L. Amling, M.D.
    Similar news · Read more »
  6. Prostate specific antigen: A review of PSA use in screening for prostate cancer
    06-18-2007 · EurekAlert!
    In this review, Drs. Ian Thompson and Donna Ankerst examine the evidence in support of using prostate specific antigen testing, and then discuss how physicians should advise patients about the merits and drawbacks of the test.
    Similar news · Read more »
  7. Tip sheet, Annals of Internal Medicine, Dec. 18, 2007, issue
    12-17-2007 · EurekAlert!
    The following articles are in the upcoming issue of Annals of Internal Medicine: "Task Force Does Not Recommend Screening for Carotid Artery Stenosis"; "Vitamin D is Standard Treatment for CKD Despite Evidence"; "Organ Donation Laws Need Revising so that Doctors Give Priority to Care for the Donor Rather than The Organ"; "Study Finds Insufficient Evidence to Decide the Most Effective Treatment to Prevent Osteoporotic Fractures"; and "Balancing Efficacy and Safety of Drug-Eluting Stents."
    Similar news · Read more »
  8. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
    08-29-2007 · UT Southwestern Medical Center
    Michael Yarborough, a 58-year-old business owner from Waxahachie, Texas, was fortunate. A routine check-up three years ago revealed prostate cancer, but a side effect of his successful surgery was "driving him nuts."
    Similar news · Read more »
  9. Finasteride artificially lowers prostate screening levels
    12-05-2006 · UT Southwestern Medical Center
    The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, a multicenter study has found.
    Similar news · Read more »
  10. MRI screening of opposite breast necessary for women with recent breast cancer diagnosis
    03-28-2007 · EurekAlert!
    Women with a recent diagnosis of cancer in one breast should have MRI screening of the opposite breast, concludes a multi-center study involving University of North Carolina at Chapel Hill researchers.
    Similar news · Read more »